NHS study into multi-cancer blood test shows real promise

hands of person holding a glass test tube
Reading Time: 2 minutes

A blood test for more than 50 types of cancer has shown real promise in a major NHS trial, researchers say.

The test correctly revealed two out of every three cancers among 5,000 people who had visited their GP with suspected symptoms, in England or Wales.

In 85% of those positive cases, it also pinpointed the original site of cancer.

The Galleri test looks for distinct changes in bits of genetic code that leak from different cancers. Spotting treatable cancer early can save lives.

The test remains very much a “work in progress”, the researchers, from Oxford University, say, but could increase the number of cancers identified.

Often, patients have symptoms, such as weight loss, with a range of possible causes and require multiple tests and hospital visits.

More than 350 of those in the study – the biggest of its kind in patients with suspected cancer symptoms – were subsequently diagnosed with cancer, using traditional methods such as scans and biopsies. About:

  • 75% of those testing positive on the blood test were found to have cancer
  • 2.5% of those testing negative were found to have cancer

The findings will be presented at the American Society of Clinical Oncology conference, in Chicago.

The NHS has also been using the Galleri test, developed by Californian company Grail, in thousands of people without symptoms, to see if it can detect hidden cancers.

Initial results are expected next year – and, if successful, the NHS in England plans to extend the rollout to a further one million people in 2024 and 2025.

The test is particularly good at finding hard-to-spot cancers such as head and neck, bowel, lung, pancreatic, and throat cancers.

Read more via BBC

Once you're here...

%d bloggers like this: